Use of anti-EGFR agents among elderly patients with metastatic colorectal cancer (mCRC).

被引：0
作者：
D'Silva, Ashley James
Dotan, Efrat
Kloth, Dwight D.
Beck, Andrew
Cohen, Steven J.
Denlinger, Crystal Shereen
机构：
[1] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
[2] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.657
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
657
引用
收藏
页数：2
相关论文
共 50 条
[31]   Liquid biopsy driven anti-EGFR rechallenge in metastatic colorectal cancer [J].
Puzzoni, M. ;
Giampieri, R. ;
Mariani, S. ;
Ziranu, P. ;
Pusceddu, V. ;
Donisi, C. ;
Persano, M. ;
Pinna, G. ;
Cimbro, E. ;
Parrino, A. ;
Pretta, A. ;
Lai, E. ;
Liscia, N. ;
Lupi, A. ;
Giglio, E. ;
Palomba, G. ;
Casula, M. ;
Pisano, M. ;
Palmieri, G. ;
Scartozzi, M. .
ANNALS OF ONCOLOGY, 2021, 32 :S543-S544
[32]   Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy [J].
Cristiana Lo Nigro ;
Vincenzo Ricci ;
Daniela Vivenza ;
Cristina Granetto ;
Teresa Fabozzi ;
Emanuela Miraglio ;
Marco C Merlano .
World Journal of Gastroenterology, 2016, (30) :6944-6954
[33]   Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer [J].
Di Fiore, F. ;
Sesbouee, R. ;
Michel, P. ;
Sabourin, J. C. ;
Frebourg, T. .
BRITISH JOURNAL OF CANCER, 2010, 103 (12) :1765-1772
[34]   Drivers of secondary resistance to anti-EGFR therapy in metastatic colorectal cancer [J].
Noseir, Soha Hussein ;
Hahn, Stephan ;
Maghnouj, Abdelouahid ;
Ladigan, Swetlana .
CANCER RESEARCH, 2020, 80 (16)
[35]   MicroRNAs and response to anti-EGFR therapy in metastatic colorectal cancer. [J].
Blanco-Calvo, Moises ;
Haz-Conde, Mar ;
Rodriguez-Rigueiro, Teresa ;
Figueroa, Angelica ;
Reboredo, Margarita ;
Medina Villaamil, Vanessa ;
Lorenzo-Patino, Maria J. ;
Arnal, Francisco ;
Anton-Aparicio, Luis ;
Alonso-Jaudenes Curbera, Guillermo ;
Valladares-Ayerbes, Manuel .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[36]   Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy [J].
Lo Nigro, Cristiana ;
Ricci, Vincenzo ;
Vivenza, Daniela ;
Granetto, Cristina ;
Fabozzi, Teresa ;
Miraglio, Emanuela ;
Merlano, Marco C. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (30) :6944-6954
[37]   Drivers of Secondary Resistance to Anti-Egfr Therapy in Metastatic Colorectal Cancer [J].
Noseir, Soha ;
Hahn, Stephan ;
Maghnouj, Abdelonahid ;
Ladigan, Swetlana .
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 :219-219
[38]   Management of Toxicity Induced by Anti-EGFR Therapy in Metastatic Colorectal Cancer [J].
Rolfo, Christian ;
Bronte, Giuseppe ;
Passiglia, Francesco ;
Papadimitriou, Konstantinos ;
Russo, Antonio ;
Peeters, Marc .
CURRENT COLORECTAL CANCER REPORTS, 2013, 9 (03) :250-260
[39]   First-line anti-EGFR or anti-VEGF therapy in metastatic colorectal cancer (mCRC) by tumour sidedness: Results from the South Australian mCRC registry [J].
Krishnan, Tharani ;
Piantadosi, Cynthia ;
Karapetis, Christos ;
Townsend, Amanda ;
Roy, Amitesh ;
Geerinckx, Barbara ;
Maddern, Guy ;
Roder, David ;
Padbury, Rob ;
Price, Timothy .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 :40-41
[40]   Comprehensive analysis of egfr and its downstream pathways deregulation identifies the vast majority of metastatic colorectal cancer (mCRC) patients resistant to anti-egfr monoclonal antibodies (MoAbs) [J].
Frattini, M. ;
Molinari, F. ;
De Dosso, S. ;
Martin, V ;
Crippa, S. ;
Saletti, P. ;
Mazzucchelli, L. .
VIRCHOWS ARCHIV, 2009, 455 :46-46
12345